2708.T
The company operates in the Food & Drug Retailing sector, generating revenue primarily through the sale of food and drug products to consumers.
Business. The company operates in the Food & Drug Retailing sector, generating revenue primarily through the sale of food and drug products to consumers.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the Food & Drug Retailing sector, generating revenue primarily through the sale of food and drug products to consumers.
The company maintains a conservative capital structure with a debt-to-equity ratio of 0.23, indicating a low reliance on debt financing. Its liquidity position is robust, with a current ratio of 1.18 and cash and equivalents amounting to 4,009,000,000 JPY, which supports short-term obligations and operational flexibility. The price-to-book ratio of 1.08 suggests that the company's market value is closely aligned with its book value, reflecting a stable valuation.
Profitability metrics show a return on equity of 22.16% and a return on assets of 7.64%, both of which are strong indicators of efficient capital use and asset management. The operating margin, calculated as operating income of 2,235,000,000 JPY on revenue of 68,568,000,000 JPY, is 3.26%, which is in line with industry norms for this sector. The gross margin of 22.91% (15,723,000,000 JPY gross profit on 68,568,000,000 JPY revenue) reflects effective cost control and pricing power.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification beyond its primary market. This lack of diversification may expose the company to regional economic fluctuations and regulatory changes, which could impact its overall performance.
The company's growth trajectory is modest, with no significant revenue growth reported in the latest financial period. The operating cash flow of 665,000,000 JPY and free cash flow of 1,653,000,000 JPY indicate that the company is generating sufficient cash to support operations and potentially fund future growth initiatives. However, the capital expenditure of -324,000,000 JPY suggests a reduction in investment in physical assets, which may affect long-term growth potential.
The risk assessment indicates a low probability of liquidity and dilution issues, with no immediate filing-based flags detected. The company's low debt levels and strong cash reserves reduce the risk of financial distress. Additionally, the absence of dilution potential and the alignment of shares outstanding (basic and diluted) suggest that the company is not currently issuing new shares to raise capital, which is a positive sign for existing shareholders.
Recent events and filings do not indicate any significant changes in the company's operations or financial strategy. The company's last actual EPS was 379.14 JPY, and its last actual revenue was 68,568,000,000 JPY, which are consistent with the financial snapshot. These figures suggest that the company is maintaining a stable performance, with no major disruptions in its business model or market position.
- The company has a strong liquidity position with a current ratio of 1.18 and significant cash reserves.
- Profitability metrics, including a 22.16% return on equity, indicate efficient capital use and asset management.
- The company's revenue is concentrated in a single business segment, which may increase exposure to regional economic fluctuations.
- The company is generating sufficient operating and free cash flow to support operations and potential growth initiatives.
- The risk assessment indicates a low probability of liquidity and dilution issues, with no immediate filing-based flags detected.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- 2708.T Market data — financials · 2026-05-26
- Kuze Co Ltd Market data — analyst estimates · 2026-05-26